Literature DB >> 32352486

Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Adrien Sanchez1, Pierre Sohier2, Sarah Benghanem3, Anne-Sophie L'Honneur4, Flore Rozenberg4, Nicolas Dupin1, Bethsabée Garel1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32352486     DOI： 10.1001/jamadermatol.2020.1704

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  34 in total

1.  A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.

Authors:  Niloufar Najar Nobari; Farnoosh Seirafianpour; Milad Dodangeh; Afsaneh Sadeghzadeh-Bazargan; Elham Behrangi; Samaneh Mozafarpoor; Azadeh Goodarzi
Journal:  Exp Dermatol       Date:  2021-05-24       Impact factor: 4.511

Review 2.  Organ-specific manifestations of COVID-19 infection.

Authors:  Maria Gavriatopoulou; Eleni Korompoki; Despina Fotiou; Ioannis Ntanasis-Stathopoulos; Theodora Psaltopoulou; Efstathios Kastritis; Evangelos Terpos; Meletios A Dimopoulos
Journal:  Clin Exp Med       Date:  2020-07-27       Impact factor: 3.984

Review 3.  Reconfiguring the scope and practice of regional anesthesia in a pandemic: the COVID-19 perspective.

Authors:  Balakrishnan Ashokka; Arunangshu Chakraborty; Balavenkat J Subramanian; Manoj Kumar Karmakar; Vincent Chan
Journal:  Reg Anesth Pain Med       Date:  2020-05-28       Impact factor: 6.288

Review 4.  Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification.

Authors:  Nikolai N Potekaev; Olga V Zhukova; Denis N Protsenko; Olga M Demina; Elena A Khlystova; Vlad Bogin
Journal:  Int J Dermatol       Date:  2020-07-03       Impact factor: 2.736

5.  The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries.

Authors:  Esther E Freeman; Devon E McMahon; Jules B Lipoff; Misha Rosenbach; Carrie Kovarik; Seemal R Desai; Joanna Harp; Junko Takeshita; Lars E French; Henry W Lim; Bruce H Thiers; George J Hruza; Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2020-07-02       Impact factor: 11.527

6.  SARS-CoV-2 as possible inducer of viral reactivations.

Authors:  Giulia Ciccarese; Aurora Parodi; Francesco Drago
Journal:  Dermatol Ther       Date:  2020-07-06       Impact factor: 3.858

Review 7.  Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.

Authors:  A V Marzano; N Cassano; G Genovese; C Moltrasio; G A Vena
Journal:  Br J Dermatol       Date:  2020-07-05       Impact factor: 11.113

8.  Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature.

Authors:  S Matar; B Oulès; P Sohier; O Chosidow; M Beylot-Barry; N Dupin; S Aractingi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-20       Impact factor: 9.228

9.  COVID-19 and cutaneous manifestations: a systematic review.

Authors:  Qing Zhao; Xiaokai Fang; Zheng Pang; Bowen Zhang; Hong Liu; Furen Zhang
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-08-26       Impact factor: 9.228

10.  SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations.

Authors:  F Drago; G Ciccarese; A Rebora; S I Muzic; A Parodi
Journal:  Br J Dermatol       Date:  2020-07-13       Impact factor: 11.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.